European Archives - Page 65 of 1322 - European Medical Journal

Advancing Skin Resilience Through Biology and Ecology

The skin, as the body’s largest organ, serves as a dynamic interface between internal systems and environmental influences. Beyond its…

malaria diagnostic

New Portable Malaria Diagnostic Detects Asymptomatic Infections in 45 Minutes

A new near point-of-care malaria diagnostic detects low-density infections in 45 minutes, supporting malaria elimination efforts across Africa.

Lower Simethicone Dose Found Equally Effective for Afternoon Colonoscopy

Lower Simethicone Dose Found Equally Effective for Afternoon Colonoscopy

A randomised trial shows 200 mg simethicone with PEG-ELS is as effective as 1200 mg for bowel cleansing and adenoma detection in afternoon colonoscopy.

taVNS therapy

Effective Rosacea Treatment Using taVNS Therapy

In a single-centre, randomised, double-blind, sham-controlled clinical trial, 72 patients with ETR were enrolled to assess the efficacy of taVNS compared with sham stimulation.

AstraZeneca to offer up to 80% off US drug prices

AstraZeneca joins Trump’s drug pricing plan, pledging $50bn US investment and discounts of up to 80% to cut prescription medicine costs.

Paediatric Infectious Diseases: Antimicrobial Stewardship in Children

From identifying viral versus bacterial infections, to optimising antibiotic use in meningitis and exploring the future of vaccines, this series provides actionable insights into safeguarding children’s health worldwide.

Embryo Metabolism Emerges as a Promising Non-Invasive Test for IVF Success

Embryo Metabolism Emerges as a Promising Non-Invasive Test for IVF Success

A global review highlights embryo metabolomics in spent culture media as a promising non-invasive method for embryo selection, paving the way for AI-integrated IVF tools.

Risk of ALS After Traumatic Brain Injury, Study Finds

Risk of ALS After Traumatic Brain Injury, Study Finds

ALS risk is heightened in the first two years after traumatic brain injury but does not remain elevated long term, suggesting reverse causality.

heart failure

Heart Failure in AML: New Evidence Emerges

A systematic review finds AML patients receiving anthracycline remission induction therapy face a significant heart failure risk, highlighting the need for enhanced cardiac monitoring.

EASD 2025 Interview: Chantal Mathieu

EASD is something very strange. It’s an association of individual members, including researchers, clinicians, and students; anybody…